Therapeutic Drug Monitoring in Pregnant Patients

Abstract

During pregnancy, there are several physiological changes during each trimester that can affect the absorption, distribution, metabolism, and elimination of drugs. Although there is a potential need to understand the pharmacokinetics and pharmacodynamics of drugs in pregnant patients, therapeutic drug monitoring is not well established for various drug classes due to ethical and safety concerns regarding the neonate. Potential risks from in utero drug exposure to the fetus may impact growth and development and may cause malformations or teratogenesis. The clinician must consider the benefits of drug treatment for the pregnant mother versus the risk to the fetus, before prescribing medications during pregnancy. The objective of this review is to aid clinicians, pharmacists, and laboratorians in understanding the pharmacokinetic and pharmacodynamic changes during pregnancy, to provide drug class recommendations for monitoring therapy throughout pregnancy via therapeutic drug monitoring, and to highlight the recent directives of governing agencies on maternal and fetal health.

Monitoring of Inflammatory Bowel Disease in Pregnancy: A Review of the Different Modalities

“…Therapeutic drug monitoring (TDM) can be a critical component in managing pregnant patients with IBD [87]. During pregnancy, physiological changes can alter the pharmacokinetics of medications, making standard dosing potentially ineffective or unsafe [88]. Evidence suggests that TDM can guide adjustments in drug dosing to maintain therapeutic levels, mitigate flares, and minimize the risk of adverse effects.…”

An Overview on Patient-Centered Clinical Services

“…Since drugs are administered to sustain and promote good health and ill conditions throughout pregnancy, these drugs may be capable of crossing the placental barrier and causing toxic effects on the fetus, TDM is needed. This method is also crucial for neonates during their treatment, but many issues are also observed 86 . Many medications, for example, must be started right away without any prior knowledge of the neonate's clinical history.…”